Metastatic solid tumor
Showing 1 - 25 of >10,000
Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)
Not yet recruiting
- Solid Tumor
- +5 more
- AZD1390
- Stereotactic Body Radiotherapy
-
New York, New York
- +1 more
Jan 12, 2023
Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- +4 more
- (no location specified)
Oct 23, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (PEP07)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 1, 2023
Advanced Or Metastatic Solid Tumor Malignancies Trial (SHR-A2102)
Not yet recruiting
- Advanced Or Metastatic Solid Tumor Malignancies
- (no location specified)
Feb 9, 2023
Metastatic Cancer Trial in Nanchang (High- and Low-dose radiotherapy)
Recruiting
- Metastatic Cancer
- High- and Low-dose radiotherapy
-
Nanchang, Jiangxi, China
- +1 more
Mar 6, 2023
Metastatic Solid Tumor, Advanced Solid Tumor Trial (XT-0528)
Not yet recruiting
- Metastatic Solid Tumor
- Advanced Solid Tumor
- (no location specified)
Jul 22, 2022
Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)
Recruiting
- Solid Tumor
- TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
- Aldesleukin
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 31, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (ART6043, Olaparib, Talazoparib)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- ART6043
- +2 more
- (no location specified)
Jun 1, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial in Nashville, Dallas, Fairfax (JZP898, Pembrolizumab)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
-
Nashville, Tennessee
- +2 more
Oct 26, 2023
NSCLC, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Duarte (JANX008)
Recruiting
- Non-Small Cell Lung Cancer
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 29, 2023
Advanced Solid Tumor, Metastatic Solid Tumor Trial (DS-3939a)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
May 12, 2023
Locally Advanced or Metastatic Solid Tumors Trial in China (IN10018+PLD, IN10018+PLD+Toripalimab)
Active, not recruiting
- Locally Advanced or Metastatic Solid Tumors
-
Anyang, Henan, China
- +6 more
Apr 25, 2023
Advanced or Metastatic Solid Tumor, KRAS G12C Mutation Trial in Changsha (BEBT-607Tablets)
Recruiting
- Advanced or Metastatic Solid Tumor
- KRAS G12C Mutation
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Nov 2, 2023
Advanced or Metastatic Solid Tumor, Liver Failure Trial in United States (Sacituzumab Govitecan-hziy)
Recruiting
- Advanced or Metastatic Solid Tumor
- Liver Failure
- Sacituzumab Govitecan-hziy
-
Long Beach, California
- +5 more
Jan 6, 2023
Solid Tumor, Adult, Metastatic Solid Tumor, Refractory Cancer Trial (ADU-1805, Pembrolizumab)
Not yet recruiting
- Solid Tumor, Adult
- +2 more
- (no location specified)
May 3, 2023
Metastatic Solid Tumor Trial (TAC01-CLDN18.2)
Not yet recruiting
- Metastatic Solid Tumor
- TAC01-CLDN18.2
- (no location specified)
May 8, 2023
Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)
Not yet recruiting
- Cancer
- +6 more
- KB707
- (no location specified)
Jul 24, 2023